Blog

MEQUON, Wis.–(BUSINESS WIRE)–Titan Spine, a medical device surface technology company focused on developing innovative spinal interbody fusion implants, today announced that data from a study comparing its proprietary surface technology to polyetheretherketone (PEEK) have now been published in the March

By Anuja Vaidya Harry Paul, a freshman at Tufts University in Boston, has invented a device that aims to improve the quality of life of children with congenital scoliosis, according to a Tufts Daily report. Mr. Paul, who suffered from congenital scoliosis

Warren, NJ, March 26, 2015 –(PR.com)– NJ-based Prosidyan™ (www.prosidyan.com), developer of proprietary fiber-based bioactive glass products, announced today that it has received FDA 510(k) clearance of FIBERGRAFT™ BG Putty – Bone Graft Substitute. This is the second generation product in

By Justin Cohen Article: Several analysts have recently weighed on NuVasive, Inc. (NASDAQ:NUVA), issuing notes to investors. William Plovanic of Canaccord Genuity reiterated their Buy rating on the stock yesterday with a $54.00 price target, or 26.26% upside to the

Washington, DC–(ENEWSPF)–April 2, 2015. The Justice Department announced today that Medtronic plc and affiliated Medtronic companies, Medtronic Inc., Medtronic USA Inc., and Medtronic Sofamor Danek USA Inc., have agreed to pay $4.41 million to the United States to resolve allegations

By Jessica Achtsam On March 31, 2015, Orthofix International N.V. announced it entered into an 18-month option agreement to acquire eNeura, Inc. Orthofix’s website states that the focus of the company is on “improving patients’ lives by providing superior reconstructive and regenerative orthopedic

A female triathlete who was cured with the use of the Sonoma CRx® Clavicle Pin will be featured in a segment on The Doctors television show that will air on April 7, 2015 on WCIU, The U. Sonoma Orthopedics is a

Although there is a high level of evidence that hip resurfacing arthroplasty preserves bone mineral density and bone stock in the proximal femur, the clinical relevance should be weighed against potential disadvantages, such as a higher revision rate f…

SynCardia says the FDA approved a clinical trial of its artificial heart as a bridge to transplant for patients with heart failure. SynCardia Systems said today that it won FDA approval for a clinical trial of its artificial heart as

FREEHOLD, N.J., April 2, 2015 /PRNewswire/ — Advanced Orthopedics and Sports Medicine Institute‘s Dr. Neil Paulvin, DO, a specialist in alternative treatments, is now board certified by the American Board of Integrative Holistic Medicine. This achievement recognizes not only Dr. Paulvin’s talent and expertise